Prefusion RSV F Immunization Elicits Th2-Mediated Lung Pathology in Mice When Formulated With a Th2 (but Not a Th1/Th2-Balanced) Adjuvant Despite Complete Viral Protection is a research paper published in Frontiers in Immunology (2020). On theSindex it has a DataRank of 0. It has been cited 65 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Allergy and Infectious Diseases
Grant: 1R43AI140941-01
An adjuvant for an RSV prefusion F vaccine that safely protects infants via maternal vaccination
National Institute of Allergy and Infectious Diseases
Grant: HHSN272200800039C
National Institute of Allergy and Infectious Diseases
Grant: HHSN272201400053C
National Institutes of Health
Grant: 1S10OD011925-01
Special BD LSRFortessaTM
National Institutes of Health
Grant: 1TL1TR001858
National Institutes of Health
Grant: 5T32AI089443-07
Autoimmunity and Immunopathology Training Program
NICHD NIH HHS
Grant: R03 HD080874
NIAID NIH HHS
Grant: U01 AI061142
NCATS NIH HHS
Grant: TL1 TR001858
NIAID NIH HHS
Grant: T32 AI089443
NIH HHS
Grant: S10 OD011925
NIAID NIH HHS
Grant: R44 AI112124
NIAID NIH HHS
Grant: R43 AI140941
National Institutes of Health
Grant: 3TL1TR001858-07S1
Administrative Supplement to NIH-funded TL1 Training Grants
National Institutes of Health
Grant: 5U01AI061142-04
Novel vaccine adjuvants to counter bioterrorist threats
Cystic Fibrosis Foundation
Eunice Kennedy Shriver National Institute of Child Health and Human Development
FWCI
4.80
Citation Percentile
1.0%
Influential Citations
2
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals